Certified OEM/ODM medical dressings, sterile gauzes, and orthopedic bandaging manufactured under stringent ISO 13485 protocols.
Global Benchmark in Medical Bandages and Advanced Wound Care Manufacturing Solutions
Hangzhou Renovera Medical Co., Ltd. is a professional manufacturer specializing in medical bandages and advanced wound care solutions, dedicated to providing safe, reliable, and high-quality healthcare consumables to global markets. With a strong focus on innovation and patient-centered care, the company serves hospitals, clinics, pharmacies, and distributors worldwide.
Renovera Medical offers a comprehensive range of products, including elastic bandages, gauze dressings, compression bandages, sterile wound dressings, and first aid supplies. Designed to support effective wound management and faster healing, its products emphasize comfort, breathability, and superior absorption performance, meeting the diverse needs of both clinical and home care applications.
Backed by modern production facilities and a skilled R&D team, Hangzhou Renovera Medical integrates advanced materials and manufacturing technologies to ensure consistent product quality and performance. The company adheres to strict international standards and quality control systems, ensuring compliance with global healthcare regulations.
Committed to long-term partnerships, Renovera Medical provides flexible OEM/ODM services tailored to customer requirements. With a growing international presence, the company continues to deliver cost-effective, high-performance wound care products, helping improve patient outcomes and supporting the evolving needs of the global healthcare industry.
Strategic shift from traditional passive absorbent pads to bioactive, low-linting, and non-adherent surgical consumables.
Transitioning from manual folding to fully automated ISO Class 8 / Class 7 cleanroom converting lines to eliminate foreign fiber contamination and maintain micro-particle counts within strict EN 13795 parameters.
Elimination of elemental chlorine gas (ECF/TCF processes) in cotton preparation. Utilization of hydrogen peroxide (H2O2) catalytic oxidation ensures zero dioxin discharge, supreme bio-compatibility, and compliance with EU REACH regulations.
Convergence of traditional woven cotton gauze with advanced hydrocolloid, sodium alginate, and ionic silver matrices. Enhancing exudate management while preventing tissue trauma during secondary dressing changes.
Rigorous alignment with European Pharmacopoeia (EP) and United States Pharmacopeia (USP) standards for absorbent cotton gauze.
| Parameter Parameter | USP Type I - IV Standard | EN 14079 European Standard | Renovera Enterprise OEM Benchmark |
|---|---|---|---|
| Yarn Count (Warp/Weft) | 20s, 32s, or 40s Combed Cotton | 20s, 32s, or 40s Purified Cotton | 40s/1 High-Tenacity Long Staple Pure Cotton |
| Mesh Density (Threads/cm²) | 13-thread, 17-thread, 20-thread | 10-thread to 28-thread range | 13, 17, 20, 24, 28 threads/cm² Precision Weave |
| Absorbency Rate (Sink Time) | < 10.0 Seconds | < 10.0 Seconds | ≤ 5.0 Seconds Rapid Capillary Wicking |
| Surface Active Agents (Foam) | Upper layer < 2mm after 5 min | No persistent foam layer | Zero Residual Detergents or Surfactants |
| Ether-Soluble Substances | < 0.70% | < 0.50% | ≤ 0.30% Ultra-Clean Textile Base |
| X-Ray Detectable Thread | Optional Barium Sulfate (BaSO4) | EN 14079 Compliant Monofilament | Heat-bonded BaSO4 filament (>60% BaSO4 content) |
| Sterilization Assurance (SAL) | 10^-6 Ethylene Oxide / Gamma | 10^-6 ISO 11135 Validated | 10^-6 Strict Cycle EO Residual < 10 ug/g |
From raw cotton selection and bleaching chemistry to sterile barrier packaging and customized regulatory dossier assembly.
100% natural, non-GMO virgin cotton fibers selected for staple length (>28mm). Continuous peroxide bleaching ensures bright whiteness (>80 R457) without compromising tensile elasticity or structural integrity.
Precision cutting and automated folding mechanisms configured for both American (USP) folded edges and European (EP) tucked edges, eliminating raw exposed threads and preventing intra-wound fiber shedding.
Multiple primary packaging systems including peelable Tyvek® pouches, medical paper/plastic blisters, and bulk non-sterile inner bags with integrated bio-indicator strips for rapid sterilization verification.
Turnkey branding services: GS1 DataMatrix barcoding, UDI (Unique Device Identification) compliance, customized outer carton art, and complete Technical File assembly for CE MDR registration.
Navigating complex international medical device frameworks with verified audit trails and regional authorization.
Transitioning from MDD to MDR requires exhaustive clinical evaluation reports (CER), post-market surveillance (PMS) architecture, and strict verification of bioburden (<100 CFU/g pre-sterilization). Hangzhou Renovera Medical provides complete technical dossier support for Class I sterile and Class IIa surgical dressings, backed by EU Authorized Representative (EC REP) integration.
Factory registration and device listing under US FDA regulations. Adherence to Quality System Regulation (QSR 21 CFR Part 820). Products undergo rigorous cytotoxicity (ISO 10993-5), sensitization (ISO 10993-10), and intracutaneous reactivity testing to ensure seamless clearance across North American healthcare networks.
Dedicated documentation team preparing legalized Certificates of Free Sale (CFS), Certificate of Pharmaceutical Product (CPP), and ISO 13485 audit reports tailored for ANVISA (Brazil), COFEPRIS (Mexico), and SFDA (Saudi Arabia) regulatory filings.
Batch-level lot tracking from raw cotton bale identification numbers to final EO chamber cycle logs. Real-time temperature and humidity tracking during international ocean freight ensures pristine sterile packaging integrity upon arrival.
Pioneering smart biosensing matrices, sustainable eco-textiles, and advanced therapeutic release mechanisms.
Development of intelligent gauze fibers embedded with non-toxic pH indicators that change color in response to elevated alkaline conditions, providing early visual alerts for bacterial infection without disturbing the wound bed.
Synthesizing natural marine-derived chitosan biopolymers onto cotton gauze fibers to impart inherent broad-spectrum antimicrobial activity against MRSA and Pseudomonas aeruginosa, minimizing reliance on topical antibiotics.
Implementation of solar-powered weaving looms and closed-loop water recycling systems. Transitioning to 100% biodegradable unbleached organic cotton options for environmentally conscious hospital procurement systems.
Direct answers for hospital purchasing officers, medical device brand managers, and regulatory directors.
The primary differentiation lies in the mesh count (warp and weft threads per inch) and mass per unit area. USP Type I represents the highest thread density (typically 24x20 threads/inch), offering maximum absorbency and structural integrity for operating room surgical sponges. Type IV represents a lighter mesh density suitable for secondary dressing wrapping and general wound cleansers. Hangzhou Renovera Medical customizes thread counts precisely to client specification requirements across all USP types.
Linting is minimized through three key engineering processes: 1) Utilizing double-combed long-staple virgin cotton fibers (>28mm length); 2) Implementing automatic folded-edge machinery that encapsulates all cut raw fabric edges inward; and 3) Passing finished gauze through high-pressure vacuum lint collectors before primary sterile packaging.
For custom branded primary pouches and outer box artwork, standard MOQs start at 50,000 units per size specification. Standard manufacturing lead time is 25–35 days post artwork approval and sterilization cycle validation. Rapid sample prototyping can be executed within 5-7 business days.
Yes. We utilize high-density Barium Sulfate (BaSO4 > 60%) monofilament threads heat-sealed or woven directly into the cotton matrix. These threads are 100% radiopaque under standard hospital X-ray imaging, ensuring immediate detection if accidentally retained in surgical cavities.
Our standard sterile line undergoes Ethylene Oxide (EO) sterilization in ISO 11135 validated chambers, achieving a Sterility Assurance Level (SAL) of 10^-6 with residual levels well below the 10 ppm requirement. We also support Gamma Radiation and Electron Beam (E-Beam) sterilization protocols based on customer market preference.
We provide complete transparency to our partners. OEM clients are provided access to complete Device Master Files (DMF), raw material certificates of analysis (CoA), sterilization validation reports, and permission for on-site facility audits by notified bodies or client quality assurance teams.
Explore our full line of bio-compatible, high-absorbency wound care products designed for global healthcare networks.
Renovera Medical
